Public Company Financial Services

Willis Towers Watson

London, England, United Kingdom

At WTW (NASDAQ: WTW), we provide data-driven, insight-led solutions in people, risk and capital—helping organizations sharpen strategy, enhance resilience, motivate their workforce, and maximize performance.

Focus Areas
Employee benefits / HR services, Insurance & risk management, Investments / private markets

Tracked deals

3

3 tracked deals across 2019-2026.

Recent pace

2

2 tracked deals announced in the last 12 months.

Deal mix

Buyout

3 buyout

Willis Towers Watson Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for Willis Towers Watson. 1 2019 ~2 est. 2 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    WTW
    Target
    Redefind
    Seller
    Redefind founders Richard Daws and Connor Edward (set to join WTW upon completion; no seller entity disclosed)
    Industry
    Insurance
    Location
    United Kingdom
    Type
    Buyout

    WTW has announced the acquisition of Redefind, an end-to-end web-based platform that enables individuals and institutions to buy insurance for cryptocurrency and other digital assets. The deal is intended to strengthen WTW’s digital strategy and integrate Redefind into its Affinity practice to expand distribution across WTW’s global client base. Financial terms were not disclosed, and Redefind founders Richard Daws and Connor Edward are set to join WTW upon completion.

  • Buyer
    WTW
    Target
    FlowStone Partners, LLC
    Location
    United States
    Type
    Buyout

    WTW completed its acquisition of FlowStone Partners, LLC on April 1, 2026. The deal adds private equity secondaries expertise to WTW’s Investments business to expand private markets solutions for individual wealth and institutional clients (financial terms undisclosed).

  • Buyer
    Willis Towers Watson
    Target
    TRANZACT
    Seller
    Clayton, Dubilier & Rice (CD&R)
    Type
    Buyout

    Willis Towers Watson has acquired TRANZACT, a U.S. direct-to-consumer sales and marketing platform for Medicare and individual life insurance, from private equity firm Clayton, Dubilier & Rice for approximately $1.2–1.3 billion (including potential earn-out). The acquisition adds TRANZACT's technology-driven lead generation, sales execution and analytics capabilities — and its ~1,300 employees (including ~850 licensed agents) — to Willis Towers Watson's Benefits Delivery and Administration business to accelerate its direct-to-consumer strategy.

Related Acquisition Pages

Selling a company? Get in front of buyers like Willis Towers Watson

Turn tracked acquisition activity into an outreach-ready buyer list.